AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
167 hedge funds and large institutions have $1.39B invested in Aerie Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 167 → 167 (0)
0% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 36
Holders
167
Holding in Top 10
8
Calls
$17.2M
Puts
$6.21M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$26.6M | |
| 3 | +$26.6M | |
| 4 |
Citigroup
New York
|
+$22.2M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$14.1M |
Top Sellers
| 1 | -$67.6M | |
| 2 | -$27.2M | |
| 3 | -$23.6M | |
| 4 |
Goldman Sachs
New York
|
-$8.64M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.29M |